BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago Leclanché nomme Jens Emrich au poste de nouveau directeur financier Stockage D'Énergie Leclanché Directeur Financier Leadership Financier Jens Emrich
BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago Leclanché SA: Jens Emrich appointed Chief Financial Officer Chief Financial Officer Appointment Financial Strategy Leclanché SA Jens Emrich
BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago Nordex Group Achieves Solid Q4/2025 Performance, Surpasses Targets Financial Targets EBITDA Margin Order Intake Nordex Group Q4 2025 Results
BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago Le groupe Nordex réalise une solide performance au quatrième trimestre 2025 et dépasse ses objectifs. Objectifs Financiers Marge D'EBITDA Groupe Nordex Prise De Commande Résultats Du T4 2025
BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago INTER PARFUMS : Résultats 2025 en Contexte Économique Tendax Marge Opérationnelle Dividende Stable Défis Économiques Inter Parfums Résultats 2025
BRIEF published on 02/25/2026 at 07:05, 2 months 19 days ago Interparfums 2025 Performance: Resilient Results Amid Challenges Dividend Interparfums Operating Margin CSR Initiatives 2025 Results
BRIEF published on 02/25/2026 at 07:04, 2 months 19 days ago OPmobility Releases 2025 Annual Results Highlighting Strong Performance and Strategic Initiatives Financial Results Operational Efficiency Carbon Neutrality Diversification Strategy Governance Stability
BRIEF published on 02/25/2026 at 06:50, 2 months 19 days ago Fresenius Reports Strong 2025 Financial Performance Financial Results Revenue Growth Dividend Proposal 2025 Performance Fresenius
BRIEF published on 02/25/2026 at 06:50, 2 months 19 days ago Fresenius annonce de solides performances financières pour 2025 Résultats Financiers Croissance Des Revenus Proposition De Dividende Fresenius Performances 2025
BRIEF published on 02/25/2026 at 06:35, 2 months 19 days ago Formycon Reports Positive Clinical Data for Keytruda® Biosimilar FYB206 Formycon AG Clinical Data Pharmacokinetic Study FYB206 Keytruda® Biosimilar
Published on 05/16/2026 at 01:15, 1 day 1 hour ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 3 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 4 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 4 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 11 hours 1 minute ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 7 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 9 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 12 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 12 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 17 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 18 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 9 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
